TPL at a subtoxic concentration not only inactivated CAFs and reversed CAFs-induced SN38 resistance, but also sensitized GC cells to SN38 by suppressing NF-κB pathway in GC cells. The gene discussed is NFKB1; the disease is gastric cancer.